- Conditions
- Efficacy and Safety
- Interventions
- Proxalutamide (GT0918), Placebo
- Drug
- Lead sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 733 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 8
- States / cities
- Phoenix, Arizona • Long Beach, California • Sandy Springs, Georgia + 5 more
Source: ClinicalTrials.gov public record
Updated Jan 1, 2024 · Synced May 22, 2026, 4:11 AM EDT